
Tuesday After-Hours Session Sees Broad Gains Across Healthcare And Biotech

I'm PortAI, I can summarize articles.
Several healthcare and biotech stocks saw significant gains in Tuesday's after-hours trading, largely without specific news driving the movements. Notable performers included Acumen Pharmaceuticals (ABOS), which rose 8.09% to $2.94, and Fulgent Genetics (FLGT), up 5.98% to $28.90. Other gainers included Fractyl Health (GUTS), Coeptis Therapeutics (COEP), and Alignment Healthcare (ALHC), among others. Amneal Pharmaceuticals (AMRX) is set to replace TTM Technologies in the S&P SmallCap 600 index on January 30.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.

